There is no cure for COVID-19. No drug completely eliminates the virus from your body or guarantees recovery. However, several approved treatments significantly reduce the severity of illness, shorten recovery time, and lower the risk of hospitalization and death. Most people with mild illness recover at home without any specialized treatment at all.
The distinction matters: available drugs work by slowing viral replication, giving your immune system time to clear the infection. They inhibit the virus rather than kill it outright. That makes them effective treatments, not cures, and their success depends heavily on how quickly you start them.
How Most People Recover
Most COVID-19 cases are mild and resolve at home. Over-the-counter pain relievers like acetaminophen or ibuprofen can manage fever, body aches, and headaches while your immune system does the heavy lifting. Rest and hydration cover the basics. For the majority of otherwise healthy people, this is the entire treatment plan, and symptoms typically clear within one to two weeks.
The people who benefit most from prescription antivirals are those at higher risk for severe disease: older adults, people with chronic conditions like diabetes or kidney disease, and those with weakened immune systems. If you fall into one of these groups and test positive, starting treatment early can make a major difference in outcomes.
Antiviral Treatments for Mild to Moderate Cases
Two oral antiviral medications are available for outpatient use, meaning you take them at home shortly after testing positive.
Paxlovid (nirmatrelvir/ritonavir) blocks a key enzyme the virus needs to copy itself. In a large California study covering December 2021 through May 2022, fewer than 1% of patients who received Paxlovid ended up hospitalized or in the emergency department in the 5 to 15 days after treatment. It works best when started within the first five days of symptoms, and ideally sooner.
Molnupiravir works differently, introducing errors into the virus’s genetic code during replication. A nationwide study of over 74,000 patients in the Czech Republic found it cut the risk of dying from COVID-19 by about 50% and reduced overall 30-day mortality by 42% compared to matched controls. Patients with kidney or liver disease saw especially strong benefits. One critical finding: molnupiravir only showed a meaningful effect when started within three days of testing positive. Patients who began treatment four or more days after their positive test saw no significant reduction in death. Molnupiravir is generally reserved for patients who can’t take Paxlovid due to drug interactions or other contraindications.
Treatment for Hospitalized Patients
For people sick enough to be admitted to the hospital, remdesivir is the primary antiviral option. It’s given intravenously, typically starting within the first two days of admission. A large study found that remdesivir reduced 14-day in-hospital mortality by about 25% and 28-day mortality by 17% in patients who didn’t yet need supplemental oxygen. That benefit held across different variants, including Delta and Omicron waves.
Hospitalized patients may also receive corticosteroids to calm an overactive immune response, along with other supportive care depending on severity. The goal at this stage shifts from stopping viral replication to preventing the immune system from damaging the lungs and other organs.
The Paxlovid Rebound Question
You may have heard about “Paxlovid rebound,” where symptoms return or a person tests positive again a few days after finishing treatment. CDC data from clinical trials found that viral rebound occurred in roughly 6% to 8% of people who took Paxlovid. But here’s the part that often gets left out: rebound happened at nearly the same rate in people who took a placebo (about 6% to 7%). The difference between the two groups was not statistically significant once researchers accounted for who had responded to treatment by day five.
Rebound symptoms typically appear 3 to 7 days after initial recovery. They’re generally mild and resolve on their own. The CDC’s position is straightforward: the benefits of treatment outweigh the risk of rebound for anyone at high risk for severe COVID-19.
Preventing Long COVID
One of the more promising findings in recent years involves metformin, a widely used diabetes medication. A phase 3 clinical trial published in The Lancet Infectious Diseases found that outpatient treatment with metformin during acute COVID-19 reduced the incidence of long COVID by about 41% over 10 months of follow-up. The drug appears to work by interfering with the virus’s ability to produce new proteins, slowing replication in a way that may prevent the kind of lingering viral activity linked to long-term symptoms.
Metformin is inexpensive, widely available, and has few drug interactions. It’s not yet a standard recommendation for COVID-19 treatment, but the trial results have drawn significant attention because long COVID remains one of the most difficult aspects of the pandemic to address, with no established treatment once it develops.
Why a True Cure Remains Elusive
COVID-19 is caused by a respiratory virus, and medicine has never produced a true cure for any common respiratory virus, including influenza or the common cold. Antiviral drugs slow replication, buying time for your immune system to eliminate the infection. That’s fundamentally different from antibiotics, which can directly kill bacteria.
The virus also mutates rapidly, which means treatments designed around one version may work differently against the next. Remdesivir’s mortality benefit held across multiple variant waves, but the landscape shifts constantly. Vaccines remain the most effective tool for preventing severe illness in the first place, working alongside treatments rather than replacing them.
The practical takeaway: COVID-19 is a treatable disease with tools that dramatically reduce the chance of severe outcomes. If you’re at higher risk and test positive, contacting a healthcare provider within the first day or two gives you the best shot at benefiting from antiviral treatment. The earlier you start, the more effective these drugs are.